Universal Registration Document 2025

Note 15 Investments in equity-accounted investees

6.6 Notes to the consolidated financial statements

Note 15 Investments in equity-accounted investees

Note 15 Investments in equity-accounted investees

Investments in equity-accounted investees
(in millions of euros) Value in balance sheet
Amount at December 31, 2023 Amount at December 31, 2023

Value in balance sheet

46
Disposals

Disposals

Value in balance sheet

Share of profit of equity-accounted investees

Share of profit of equity-accounted investees

Value in balance sheet

(2)

Capital increases

Capital increases

Value in balance sheet

39

Dividends paid

Dividends paid

Value in balance sheet

(4)

Foreign exchange and others

Foreign exchange and others

Value in balance sheet

Amount at December 31, 2024 Amount at December 31, 2024

Value in balance sheet

79
Disposals

Disposals

Value in balance sheet

(8)

Share of profit of equity-accounted investees

Share of profit of equity-accounted investees

Value in balance sheet

3

Capital increases

Capital increases

Value in balance sheet

Dividends paid

Dividends paid

Value in balance sheet

(5)

Foreign exchange and others

Foreign exchange and others

Value in balance sheet

(1)

Amount at December 31, 2025

Amount at December 31, 2025

Value in balance sheet

68

In 2025, the Group disposed of its subsidiary MSL France, which held a 50% interest in Viva Tech — a joint venture between MSL France and Les Échos Solutions - that had previously been accounted for using the equity method. This transaction forms part of a broader effort to streamline the scope and refocus strategically on the Group’s core activities. The disposal, completed in the second half of the year, was carried out for euro 5 million, corresponding to the fair value of the shares at the transaction date. The deconsolidation generated a disposal gain of euro 2 million, recognized in non-current income (see Note 8), reflecting the difference between the sale price and the net carrying amount of the investment. Viva Tech was derecognized from the scope of equity-accounted investments as of the disposal date.

In 2024, the Groupe completed capital increases in Unlimitail (equity-accounted investee), in which it held a 49% stake. The total amount of the contributions amounted to euro 105 million, of which euro 51 million contributed by the Groupe (proportionate to its investment):

  • euro 27 million corresponding to exclusive rights for the use of Citrus and Epsilon technologies;
  • euro 24 million in cash.

The gain from this transaction, amounting to €14 million, was recognized in non-current income after eliminating the internal share of profit (see Note 8).

The following table shows the carrying amount of investments in equity-accounted investees as of December 31, 2025:

the carrying amount of investments in equity-accounted investees as of December 31, 2025
(in millions of euros) December 31, 2025
Magalas Limited

Magalas Limited

December 31, 2025

18

OnPoint Consulting Inc.

OnPoint Consulting Inc.

December 31, 2025

2

SCB TechX

SCB TechX

December 31, 2025

15

Somupi SA

Somupi SA

December 31, 2025

3

Unlimitail

Unlimitail

December 31, 2025

25

Other investments in equity-accounted investees

Other investments in equity-accounted investees

December 31, 2025

5

Net amount

Net amount

December 31, 2025

68